A randomized, crossover, controlled Japanese trial examining the use of electronic Patient-Reported Outcomes to improve medication adherence by outpatient Pharmacists.

A randomized, crossover, controlled Japanese trial examining the use of electronic Patient-Reported Outcomes to improve medication adherence by outpatient Pharmacists. - JPRO-P

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043330

Enrollment

100

Registered

2021-02-16

Start date

2021-06-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation, Venous thromboembolism

Interventions

Fill out the electronic patient-reported outcome(ePRO) daily for medications and side effects during first month. Take medication as usual for next month without ePRO. Take medication as usual for fir

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who are taking anticoagulants (warfarin, dabigatran, edoxaban, rivaroxaban, apixaban). 2) Patients who are able to use a cell phone or computer. 3) Patients who have received sufficient explanation and understanding of the study, and have given their free written consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Patients who were judged by the physician in charge to be inappropriate as subjects. 2) In addition, patients who were judged by Principal Investigator to be unsuitable for participation in this study.

Design outcomes

Primary

Measure	Time frame
Medication adherence rate	—

Countries

Japan

Contacts

Public ContactRie Ozeki

Juntendo Univerity School of Medicine Breast Oncology

r.ozeki.gs@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026